Nektar Therapeutics (NKTR) Goodwill (2010 - 2022)

Nektar Therapeutics' Goodwill history runs 13 years deep, the most recent figure standing at $76.5 million for Q4 2022.

• On a quarterly basis, Goodwill changed 0.0% year-over-year to $76.5 million in Q4 2022; TTM through Dec 2022 was $76.5 million, a 0.0% change from a year earlier, with the FY2022 full-year figure at $76.5 million, changed 0.0% from the prior year.
• Goodwill was little changed at $76.5 million in Q4 2022 per NKTR's latest filing, from $76.5 million in the prior quarter.
• Across five years, Goodwill topped out at $76.5 million in Q1 2018 and bottomed at $76.5 million in Q1 2018.
• The 5-year median for Goodwill is $76.5 million (2018), against an average of $76.5 million.
• Biggest YoY gain for Goodwill was 0.0% in 2018; the steepest drop was 0.0% in 2018.
• Year by year, Goodwill stood at $76.5 million in 2018, then changed by 0.0% to $76.5 million in 2019, then changed by 0.0% to $76.5 million in 2020, then changed by 0.0% to $76.5 million in 2021, then changed by 0.0% to $76.5 million in 2022.
• Per Business Quant, the three latest NKTR Goodwill figures stand at $76.5 million (Q4 2022), $76.5 million (Q3 2022), and $76.5 million (Q2 2022).